Kestra Medical Technologies, Ltd. Common Stock logo

KMTS Earnings Date: Dec 10, 2026 (Estimated) — Kestra Medical Technologies, Ltd. Common Stock

XNAS · Healthcare · Medical Instruments & Supplies

Updated

Price $30.61
Market Cap $1.8B
P/E —
52W Range $17.34 – $31.04
Next Earnings · After close (est.)

When is KMTS's next earnings date?

Kestra Medical Technologies, Ltd. Common Stock (KMTS) is expected to report Q2 2027 earnings on Thursday, December 10, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.61 on revenue of $32.0M.

How did KMTS do in its last earnings report?

In its most recent report on Sep 14, 2026 (Q1 2027), Kestra Medical Technologies, Ltd. Common Stock posted EPS of -$0.75 versus the -$0.62 estimate, a miss of 21.0%. Revenue was $31.0M against a $29.0M estimate. The stock's 1-day post-earnings move was +4.7%.

How much does KMTS stock move after earnings?

KMTS beat EPS estimates in 1 of its last 6 reported quarters. Over the last 6 reports the stock moved an average of 6.5% (up or down) in the day after earnings.

About Kestra Medical Technologies, Ltd. Common Stock

Kestra Medical Technologies Ltd is a commercial-stage wearable medical device and digital healthcare company focused on connected monitoring, therapeutic intervention, and data-driven clinical insights for cardiovascular disease. It has developed and is commercializing the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. The platform is anchored by the ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected. The platform also includes digital patient engagement and clinical workflow solutions.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-09-14Q1 2027-0.62-0.75-20.97%$31.0M❌ Miss+4.66%+2.95%+12.09%
2026-07-14Q4 2026-0.58-0.67-15.52%$28.6M❌ Miss+1.80%-8.02%+15.80%
2026-03-17Q3 2026-0.60-0.61-1.67%$24.6M❌ Miss-7.38%-2.08%-3.45%
2025-12-11Q2 2026-0.57-0.64-12.28%$22.6M❌ Miss+5.06%+8.99%-11.52%
2025-09-11Q1 2026-0.73-0.50+31.51%$19.4M✅ Beat+18.64%+36.96%+19.57%
2025-04-14Q3 2025-0.64-1.25-95.31%$15.1M❌ Miss+1.26%+0.71%-6.00%
2021-07-31—-0.27——————

Showing last 7 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .